Minnesota MED company Vireo has secured a patent for “tobacco products infused with cannabis,” which it plans to market as a safer alternative to tobacco. Don’t expect to see cannabis infused cigarettes on shelves any time soon.

  • Based on available studies, Vireo claims cannabinoids “can have anti-inflammatory properties, which could help ease tobacco-related irritation of the mouth and throat.” It also suggests cannabinoid infused tobacco “may also reduce cancer risks from smoking,” citing studies in mice.
  • Vireo CEO Kyle Kingsley is a board certified physician.
  • Two former Vireo executives face criminal charges in Minnesota for allegedly driving $500,000 of MED oil from Minnesota to New York.

Quick hits

  1. E-cigarette powerhouse Juul has committed to stop teen vaping, but the N.Y. Times reports its lobbying in state capitols “runs counter to that pledge.”
  2. Oregon-based Phylos Biosciences has solicited strains for its Galaxy database, and now faces an uproar from growers who feel mislead about the company’s intentions for their genetics.
    cannabis now
  3. wrote about cannabis addiction for the Guardian.